Back
Yangtze Optical Fibre and Cable Joint Stock Ltd 10K Form
Sell
31
YZOFF
Yangtze Optical Fibre and Cable Joint Stock Ltd
Last Price:
1.03
Seasonality Move:
2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive YZOFF News And Ratings
See the #1 stock for the next 7 days that we like better than YZOFF
YZOFF Financial Statistics
Sales & Book Value
Annual Sales: | $1.89B |
---|---|
Cash Flow: | $-80.95M |
Price / Cash Flow: | 0 |
Annual Sales: | $2.06 |
Price / Book: | 0.5 |
Profitability
EPS (TTM): | 0.17440 |
---|---|
Net Income (TTM): | $132.04M |
Gross Margin: | $462.56M |
Return on Equity: | 6.84% |
Return on Assets: | 3.17% |
Yangtze Optical Fibre and Cable Joint Stock Ltd Earnings Forecast
Key Yangtze Optical Fibre and Cable Joint Stock Ltd Financial Ratios
- The Gross Profit Margin over the past 11 years for YZOFF is 24.50%.
- The Selling, General & Administrative Expenses for YZOFF have been equal to 4.23% of Gross Profit Margin.
- The Research & Development expenses have been 5.80% of Revenue.
- The Interest Expense is 17.66% of Operating Income.
- The Net Earning history of YZOFF is 9.72% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 7 years.
Yangtze Optical Fibre and Cable Joint Stock Ltd Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Communications Equipment |
Sector: | Information Technology |
Current Symbol: | YZOFF |
Website: | yofc.com |
Debt
Debt-to-Equity Ratio: | 0.88 |
---|---|
Current Ratio: | 1.78 |
Quick Ratio: | 1.35 |
Price-to-Earnings
Trailing P/E Ratio: | 4.26 |
---|---|
Forward P/E Ratio: | 0 |
YZOFF Technical Analysis vs Fundamental Analysis
Sell
31
Yangtze Optical Fibre and Cable Joint Stock Ltd (YZOFF)
is a Sell
Is Yangtze Optical Fibre and Cable Joint Stock Ltd a Buy or a Sell?
-
Yangtze Optical Fibre and Cable Joint Stock Ltd stock is rated a Sell
The current Yangtze Optical Fibre and Cable Joint Stock Ltd [YZOFF] share price is $1.03. The Score for YZOFF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.